Business, energy, technology, markets and global industry news from Business News Today

CPSE

PharmaDeviceNews CPSE
Representative image of AI-driven heart failure monitoring at home, showing how Coredio’s FDA breakthrough-designated platform could extend advanced cardiac assessment beyond hospital settings through wearables, blood pressure cuffs, and remote clinical review.
Medical Devices & Diagnostics

FDA breakthrough status gives Coredio’s AI heart failure platform a faster regulatory path

Coredio’s AI heart failure platform may bring hemodynamic insight into home care. See why FDA breakthrough status matters now.

Read More